D
Exousia Bio, Inc. LMMY
$0.44 $0.0821.69% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Corporate Info
Phone Number
509 605 6533
Address
7901 4th Street N
#23494
Saint Petersburg, FL 33702
Country
United States
Year Founded
2022
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company’s platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026. The company was incorporated in 2022 and is based in Saint Petersburg, Florida.